Next-Generation Sequencing for Veterinary Pathogen Metagenomics
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Metagenomic next-generation sequencing (mNGS) offers an unbiased approach to pathogen detection in veterinary diagnostics, capable of identifying known, novel, or co-infecting agents without prior sequence knowledge, unlike targeted methods such as PCR.
- The mNGS workflow involves robust nucleic acid extraction from diverse veterinary sample types (feces, blood, tissue, swabs, arthropods), followed by library preparation (including reverse transcription for RNA viruses), high-throughput sequencing, and sophisticated bioinformatics pipelines for quality control, host read subtraction, and taxonomic classification.
- mNGS has been instrumental in discovering novel viral pathogens in various animal species, including swine, cattle, canines, and avian populations, and has also proven effective for identifying bacterial and parasitic agents and characterizing complex microbiomes.
- Beyond pathogen identification, mNGS enables simultaneous profiling of antimicrobial resistance (AMR) genes within a sample, providing critical insights into the resistome of veterinary pathogens and potential reservoirs of resistance determinants.
- Significant challenges to routine mNGS adoption in veterinary diagnostics include high costs, the need for specialized bioinformatics expertise, potential for false positives from contamination, and the necessity for standardized, validated protocols for clinical interpretation and regulatory approval.
- Future advancements in sequencing technology and bioinformatics are expected to reduce costs and turnaround times, potentially enabling real-time field diagnostics and integration into One Health surveillance networks for early detection of zoonotic threats.
Introduction
The application of next-generation sequencing (NGS) to metagenomic analysis has fundamentally altered the landscape of veterinary pathogen detection and discovery. Unlike targeted molecular assays such as polymerase chain reaction (PCR), which require a priori knowledge of the pathogen's genetic sequence, metagenomic next-generation sequencing (mNGS) enables the unbiased detection of all nucleic acids present in a clinical sample [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. This capability is particularly valuable in veterinary medicine, where the diversity of potential pathogens across multiple host species is immense and where emerging or novel agents frequently evade conventional diagnostic panels [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. The core principle of mNGS involves the extraction of total nucleic acid from a specimen, followed by high-throughput sequencing and computational analysis to identify microbial sequences against reference databases [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. This approach has been successfully applied to many veterinary contexts, including the characterization of viral diversity in diarrheic swine feces [<a href="#ref-7">7</a>], the detection of tick-borne pathogens in livestock and companion animals [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>], and the discovery of novel viruses in wildlife populations [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. The inherent agnosticism of mNGS makes it a powerful tool for both clinical diagnostics and pathogen surveillance within a One Health framework [<a href="#ref-2">2</a>, <a href="#ref-4">4</a>].
Technical Foundations of Metagenomic Sequencing
Nucleic Acid Extraction and Library Preparation
The success of any mNGS workflow is contingent upon the quality and quantity of nucleic acid recovered from the sample. For veterinary specimens, which may include feces, blood, tissue biopsies, swabs, or arthropod vectors, the extraction protocol must be optimized to lyse a broad spectrum of microbial cell types, including hard-to-disrupt viruses, bacteria, fungi, and parasites [<a href="#ref-4">4</a>, <a href="#ref-11">11</a>]. Mechanical lysis methods, such as bead-beating, are often employed to ensure the release of nucleic acids from robust pathogens [<a href="#ref-11">11</a>]. Following extraction, the nucleic acid is subjected to library preparation, a process that involves fragmentation, end-repair, adapter ligation, and amplification [<a href="#ref-6">6</a>]. For RNA-based metagenomics, a reverse transcription step is required prior to library construction [<a href="#ref-11">11</a>]. The choice between DNA and RNA sequencing can be guided by the suspected pathogen type; RNA sequencing is particularly advantageous for detecting RNA viruses, which constitute a large proportion of emerging zoonotic agents [<a href="#ref-2">2</a>, <a href="#ref-4">4</a>]. Probe-based enrichment strategies, which use biotinylated oligonucleotide probes to capture specific pathogen genomes from the metagenomic pool, have been developed to increase the sensitivity of detection for low-abundance targets [<a href="#ref-12">12</a>, <a href="#ref-13">13</a>]. Hybridization capture sequencing has been shown to enhance the detection of bovine respiratory disease pathogens and associated antimicrobial resistance genes from complex samples [<a href="#ref-13">13</a>].
Sequencing Platforms and Throughput
High-throughput sequencing platforms generate millions to billions of short reads per run, providing the depth necessary to detect minority populations within a metagenomic sample [<a href="#ref-6">6</a>]. The fundamental chemistry of these platforms involves the clonal amplification of DNA fragments on a solid surface, followed by cyclic reversible termination sequencing [<a href="#ref-6">6</a>]. Read lengths typically range from 75 to 300 base pairs, which are sufficient for taxonomic classification when compared against comprehensive reference databases [<a href="#ref-5">5</a>]. Long-read sequencing technologies, which produce reads exceeding 10 kilobases, offer advantages in resolving repetitive genomic regions and assembling complete viral genomes from complex metagenomic data [<a href="#ref-6">6</a>]. The choice of platform involves a trade-off between throughput, read length, cost, and turnaround time, with short-read platforms generally providing higher per-base accuracy and long-read platforms enabling more contiguous genome assemblies [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>].
Bioinformatics Pipelines for Pathogen Detection
The computational analysis of mNGS data is a multi-step process that transforms raw sequencing reads into actionable pathogen identifications. A typical pipeline includes quality control, host read subtraction, taxonomic classification, and visualization [<a href="#ref-2">2</a>, <a href="#ref-5">5</a>]. The first step involves trimming adapter sequences and filtering low-quality reads to reduce noise [<a href="#ref-5">5</a>]. Host-derived sequences, which often constitute the vast majority of reads in a clinical sample, must be removed by aligning reads to the host reference genome [<a href="#ref-4">4</a>]. This subtraction step is critical for increasing the sensitivity of pathogen detection by enriching the pool of microbial reads [<a href="#ref-2">2</a>].
Taxonomic classification is performed using either alignment-based or k-mer-based algorithms. Alignment-based tools map reads directly to a reference database of known microbial genomes, while k-mer-based tools decompose reads into short subsequences of length k and compare them against a pre-indexed database of k-mers from reference genomes [<a href="#ref-5">5</a>]. The output of these classifiers is a list of taxa with associated read counts, which must be interpreted with caution to avoid false positives from environmental contaminants or sequencing artifacts [<a href="#ref-5">5</a>]. Pipelines such as TaxTriage have been developed to provide a user-friendly, open-source framework for putative pathogen detection, incorporating steps for read filtering, taxonomic assignment, and report generation [<a href="#ref-5">5</a>]. For viral metagenomics, the recovery of complete or near-complete viral genomes is often a primary goal, as it enables phylogenetic analysis and the identification of genetic markers associated with virulence or host range [<a href="#ref-4">4</a>, <a href="#ref-10">10</a>, <a href="#ref-14">14</a>].
flowchart TD
A["Clinical Sample Collection"] --> B["Nucleic Acid Extraction"]
B --> C{"Sequencing Target"}
C -->|"DNA"| D["DNA Library Preparation"]
C -->|"RNA"| E["Reverse Transcription & cDNA Library Prep"]
D --> F["High-Throughput Sequencing"]
E --> F
F --> G["Raw Read Output"]
G --> H["Quality Control & Adapter Trimming"]
H --> I["Host Read Subtraction"]
I --> J["Taxonomic Classification"]
J --> K["Pathogen Identification & Genome Assembly"]
K --> L["Clinical Interpretation & Reporting"]Applications in Veterinary Pathogen Discovery and Surveillance
Viral Pathogens
Metagenomic sequencing has been instrumental in the discovery of novel viruses across many animal hosts. In swine, mNGS analysis of diarrheic fecal samples has revealed a complex viral community, including known enteric pathogens and previously uncharacterized viruses [<a href="#ref-7">7</a>]. The technique has also been used to characterize the genetic diversity of porcine reproductive and respiratory syndrome virus (PRRSV) in live virus inoculation material, demonstrating its utility in quality control for vaccine development [<a href="#ref-1">1</a>]. In cattle, mNGS has enabled the identification of novel astroviruses associated with enteric disease in goat kids [<a href="#ref-14">14</a>] and the long-term detection of hepacivirus genotypes on a single farm [<a href="#ref-15">15</a>]. The detection of a novel parvovirus circulating in canine populations, with sporadic spillover into human oropharyngeal samples, highlights the zoonotic potential of agents discovered through veterinary metagenomics [<a href="#ref-16">16</a>]. Avian species have also been a rich source of novel viral diversity, with mNGS revealing multiple viruses in monk parakeets [<a href="#ref-17">17</a>] and a highly divergent parvovirus in the critically endangered western ground parrot [<a href="#ref-18">18</a>]. In equine medicine, NGS has been applied to the cytological and molecular characterization of viral pathogens involved in respiratory disease [<a href="#ref-19">19</a>].
Bacterial and Parasitic Pathogens
Beyond virology, mNGS is a powerful tool for the detection of bacterial and parasitic agents. The technique has been used to identify a potentially undescribed columnaris-causing bacterium in rainbow trout [<a href="#ref-20">20</a>] and to reconstruct the genome of Bacillus anthracis from complex environmental samples for high-throughput lineage assignment [<a href="#ref-21">21</a>]. In companion animals, mNGS has facilitated the first report of Castellaniella spp. infection in dogs [<a href="#ref-22">22</a>] and the metagenomic assembly of Lawsonella clevelandensis from canine external otitis [<a href="#ref-23">23</a>]. The characterization of the healthy canine skin microbiome using mNGS provides a baseline against which dysbiosis associated with disease can be measured [<a href="#ref-24">24</a>]. For vector-borne diseases, mNGS has been applied to ticks collected from livestock and companion animals, revealing a diverse array of bacterial, viral, and parasitic pathogens [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>]. The identification of phleboviruses in Rhipicephalus simus ticks expands the known host range for this viral genus [<a href="#ref-25">25</a>]. In wildlife, mNGS of small mammals in Myanmar detected Wencheng shrew virus and cardioviruses [<a href="#ref-26">26</a>], while analysis of Mastomys natalensis rodents in Zambia revealed evidence of multiple infectious disease agents [<a href="#ref-27">27</a>].
Antimicrobial Resistance Profiling
Metagenomic sequencing can simultaneously detect pathogens and their associated antimicrobial resistance (AMR) genes, providing a comprehensive view of the resistome within a sample [<a href="#ref-13">13</a>, <a href="#ref-28">28</a>]. This is particularly relevant for veterinary medicine, where the judicious use of antimicrobials is a critical concern. Hybridization capture sequencing has been shown to enhance the detection of AMR genes in bovine respiratory disease samples, allowing for the identification of resistance determinants that may be present at low abundance [<a href="#ref-13">13</a>]. Analysis of the oral microbiome of grey wolves has revealed a diverse array of AMR genes, underscoring the role of wildlife as reservoirs for resistance determinants [<a href="#ref-28">28</a>].
Challenges and Limitations
Despite its transformative potential, the routine implementation of mNGS in veterinary diagnostics faces several challenges. The high cost of sequencing and the requirement for specialized bioinformatics expertise remain significant barriers for many diagnostic laboratories [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>]. The sensitivity of mNGS for pathogen detection can be limited by the overwhelming abundance of host nucleic acid, particularly in tissue samples, necessitating the use of host depletion or enrichment strategies [<a href="#ref-4">4</a>, <a href="#ref-12">12</a>]. The presence of contaminating nucleic acids in reagents and the laboratory environment can lead to false-positive results, requiring the inclusion of appropriate negative controls and rigorous bioinformatic filtering [<a href="#ref-5">5</a>]. The interpretation of metagenomic data requires careful consideration of the clinical context, as the detection of a potential pathogen does not necessarily imply causation of disease [<a href="#ref-2">2</a>]. Standardization of protocols and the development of validated, regulatory-approved workflows are needed to facilitate the broader adoption of mNGS in veterinary clinical practice [<a href="#ref-6">6</a>].
Frequently Asked Questions
What is the primary advantage of metagenomic next-generation sequencing over targeted PCR for veterinary diagnostics?
The primary advantage of mNGS is its ability to detect any pathogen without requiring prior knowledge of its genetic sequence, enabling the identification of novel, unexpected, or co-infecting agents in a single assay [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>].
How does host nucleic acid subtraction improve pathogen detection in mNGS?
Host subtraction removes the majority of sequencing reads derived from the animal's own genome, thereby enriching the remaining dataset for microbial sequences and increasing the statistical power to detect low-abundance pathogens [<a href="#ref-2">2</a>, <a href="#ref-4">4</a>].
What types of veterinary samples are suitable for metagenomic sequencing?
many sample types are suitable, including feces, blood, serum, tissue biopsies, swabs (nasal, oral, rectal), cerebrospinal fluid, and arthropod vectors such as ticks and mosquitoes [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-8">8</a>, <a href="#ref-9">9</a>, <a href="#ref-11">11</a>].
Can mNGS distinguish between live and dead pathogens?
Standard mNGS detects nucleic acids and cannot differentiate between viable and non-viable organisms. The detection of RNA may be a better indicator of recent or active infection due to its more rapid degradation compared to DNA [<a href="#ref-2">2</a>, <a href="#ref-11">11</a>].
What bioinformatics resources are required for analyzing mNGS data?
Analysis requires access to high-performance computing resources, comprehensive reference databases of microbial genomes, and specialized software pipelines for quality control, host subtraction, and taxonomic classification [<a href="#ref-2">2</a>, <a href="#ref-5">5</a>].
How is the clinical significance of a detected pathogen determined?
Clinical significance is assessed by considering the abundance of the pathogen's reads, the presence of the pathogen in relevant anatomical sites, correlation with clinical signs and histopathology, and the exclusion of environmental contaminants [<a href="#ref-2">2</a>, <a href="#ref-5">5</a>].
What are the main limitations preventing widespread adoption of mNGS in veterinary clinics?
The main limitations include high cost, long turnaround times, the need for specialized bioinformatics expertise, challenges in data interpretation, and a lack of standardized, validated protocols for regulatory approval [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>].
Future Directions
The future of veterinary pathogen metagenomics lies in the integration of mNGS into routine diagnostic workflows and surveillance programs. Advances in sequencing technology are expected to reduce costs and turnaround times, making mNGS more accessible to veterinary diagnostic laboratories [<a href="#ref-6">6</a>]. The development of portable sequencing devices may enable real-time pathogen detection in field settings, such as on farms or in wildlife reserves [<a href="#ref-6">6</a>, <a href="#ref-29">29</a>]. Improvements in bioinformatics, including the application of machine learning for pathogen classification and the development of user-friendly interfaces, will lower the barrier to data analysis [<a href="#ref-5">5</a>]. The incorporation of mNGS into One Health surveillance networks will facilitate the early detection of emerging zoonotic pathogens with pandemic potential, bridging the gap between animal and human health [<a href="#ref-2">2</a>, <a href="#ref-4">4</a>]. The continued characterization of the animal microbiome will provide a deeper understanding of the complex interactions between the host, its commensal microbiota, and invading pathogens [<a href="#ref-24">24</a>, <a href="#ref-28">28</a>].